FXR1a-associated microRNP: A driver of specialized non-canonical translation in quiescent conditions

References

• Jonas S, Izaurralde E. Towards a molecular understanding of microRNA-mediated gene silencing. Nat Rev Genet 2015; 16:421-33; PMID:26077373; http://dx.doi.org/10.1038/nrg3965
   PubMed Web of Science ®Google Scholar
• He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5:522-31; PMID:15211354; http://dx.doi.org/10.1038/nrg1379
   PubMed Web of Science ®Google Scholar
• Farazi TA, Spitzer JI, Morozov P, Tuschl T. miRNAs in human cancer. J Pathol 2011; 223:102-15; PMID:21125669; http://dx.doi.org/10.1002/path.2806
   PubMed Web of Science ®Google Scholar
• Ameres SL, Zamore PD. Diversifying microRNA sequence and function. Nat Rev Mol Cell Biol 2013; 14:475-88; PMID:23800994; http://dx.doi.org/10.1038/nrm3611
   PubMed Web of Science ®Google Scholar
• Hutvagner G, Simard MJ. Argonaute proteins: key players in RNA silencing. Nat Rev Mol Cell Biol 2008; 9:22-32; PMID:18073770; http://dx.doi.org/10.1038/nrm2321
   PubMed Web of Science ®Google Scholar
• Chi SW, Zang JB, Mele A, Darnell RB. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 2009; 460:479-86; PMID:19536157; http://dx.doi.org/10.1038/nature08170
   PubMed Web of Science ®Google Scholar
• Rana TM. Illuminating the silence: understanding the structure and function of small RNAs. Nat Rev Mol Cell Biol 2007; 8:23-36; PMID:17183358; http://dx.doi.org/10.1038/nrm2085
   PubMed Web of Science ®Google Scholar
• Fabian MR, Sundermeier TR, Sonenberg N. Understanding how miRNAs post-transcriptionally regulate gene expression. Prog Mol Subcell Biol 2010; 50:1-20; PMID:19841878; http://dx.doi.org/10.1007/978-3-642-03103-8_1
   PubMedGoogle Scholar
• Chekulaeva M, Filipowicz W. Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr Opin Cell Biol 2009; 21:452-60; PMID:19450959; http://dx.doi.org/10.1016/j.ceb.2009.04.009
   PubMed Web of Science ®Google Scholar
• Meijer HA, Kong YW, Lu WT, Wilczynska A, Spriggs RV, Robinson SW, Godfrey JD, Willis AE, Bushell M. Translational repression and eIF4A2 activity are critical for microRNA-mediated gene regulation. Science 2013; 340:82-5; PMID:23559250; http://dx.doi.org/10.1126/science.1231197
   PubMed Web of Science ®Google Scholar
• Moretti F, Kaiser C, Zdanowicz-Specht A, Hentze MW. PABP and the poly(A) tail augment microRNA repression by facilitated miRISC binding. Nat Struct Mol Biol 2012; 19:603-8; PMID:22635249; http://dx.doi.org/10.1038/nsmb.2309
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136:215-33; PMID:19167326; http://dx.doi.org/10.1016/j.cell.2009.01.002
   PubMed Web of Science ®Google Scholar
• Takacs CM, Giraldez AJ. MicroRNAs as genetic sculptors: fishing for clues. Semin Cell Dev Biol 2010; 21:760-7; PMID:20152922; http://dx.doi.org/10.1016/j.semcdb.2010.02.003
   PubMed Web of Science ®Google Scholar
• Djuranovic S, Nahvi A, Green R. A parsimonious model for gene regulation by miRNAs. Science 2011; 331:550-3; PMID:21292970; http://dx.doi.org/10.1126/science.1191138
   PubMed Web of Science ®Google Scholar
• Humphreys DT, Westman BJ, Martin DI, Preiss T. MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. Proc Natl Acad Sci U S A 2005; 102:16961-6; PMID:16287976; http://dx.doi.org/10.1073/pnas.0506482102
   PubMed Web of Science ®Google Scholar
• Vasudevan S, Steitz JA. AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2. Cell 2007; 128:1105-18; PMID:17382880; http://dx.doi.org/10.1016/j.cell.2007.01.038
   PubMed Web of Science ®Google Scholar
• Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007; 318:1931-4; PMID:18048652; http://dx.doi.org/10.1126/science.1149460
   PubMed Web of Science ®Google Scholar
• Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005; 309:1577-81; PMID:16141076; http://dx.doi.org/10.1126/science.1113329
   PubMed Web of Science ®Google Scholar
• Henke JI, Goergen D, Zheng J, Song Y, Schuttler CG, Fehr C, Jünemann C, Niepmann M. microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J 2008; 27:3300-10; PMID:19020517; http://dx.doi.org/10.1038/emboj.2008.244
   PubMed Web of Science ®Google Scholar
• Orom UA, Nielsen FC, Lund AH. MicroRNA-10a binds the 5′UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell 2008; 30:460-71; PMID:18498749; http://dx.doi.org/10.1016/j.molcel.2008.05.001
   PubMed Web of Science ®Google Scholar
• Iwasaki S, Tomari Y. Argonaute-mediated translational repression (and activation). Fly (Austin) 2009; 3:204-6; PMID:19556851; http://dx.doi.org/10.4161/fly.3.3.9025
   PubMed Web of Science ®Google Scholar
• Lin CC, Liu LZ, Addison JB, Wonderlin WF, Ivanov AV, Ruppert JM. A KLF4-miRNA-206 autoregulatory feedback loop can promote or inhibit protein translation depending upon cell context. Mol Cell Biol 2011; 31:2513-27; PMID:21518959; http://dx.doi.org/10.1128/MCB.01189-10
   PubMed Web of Science ®Google Scholar
• Tserel L, Runnel T, Kisand K, Pihlap M, Bakhoff L, Kolde R, Peterson H, Vilo J, Peterson P, Rebane A. MicroRNA expression profiles of human blood monocyte-derived dendritic cells and macrophages reveal miR-511 as putative positive regulator of Toll-like receptor 4. J Biol Chem 2011; 286:26487-95; PMID:21646346; http://dx.doi.org/10.1074/jbc.M110.213561
   PubMed Web of Science ®Google Scholar
• Roberts AP, Lewis AP, Jopling CL. miR-122 activates hepatitis C virus translation by a specialized mechanism requiring particular RNA components. Nucleic Acids Res 2011; 39:7716-29; PMID:21653556; http://dx.doi.org/10.1093/nar/gkr426
   PubMed Web of Science ®Google Scholar
• Mortensen RD, Serra M, Steitz JA, Vasudevan S. Posttranscriptional activation of gene expression in Xenopus laevis oocytes by microRNA-protein complexes (microRNPs). Proc Natl Acad Sci U S A 2011; 108:8281-6; PMID:21536868; http://dx.doi.org/10.1073/pnas.1105401108
   PubMed Web of Science ®Google Scholar
• Zhang X, Zuo X, Yang B, Li Z, Xue Y, Zhou Y, Huang J, Zhao X, Zhou J, Yan Y, et al. MicroRNA directly enhances mitochondrial translation during muscle differentiation. Cell 2014; 158:607-19; PMID:25083871; http://dx.doi.org/10.1016/j.cell.2014.05.047
   PubMed Web of Science ®Google Scholar
• Kirkpatrick LL, McIlwain KA, Nelson DL. Alternative splicing in the murine and human FXR1 genes. Genomics 1999; 59:193-202; PMID:10409431; http://dx.doi.org/10.1006/geno.1999.5868
   PubMed Web of Science ®Google Scholar
• Dube M, Huot ME, Khandjian EW. Muscle specific fragile X related protein 1 isoforms are sequestered in the nucleus of undifferentiated myoblast. BMC Genet 2000; 1:4; PMID:11178106; http://dx.doi.org/10.1186/1471-2156-1-4
   PubMedGoogle Scholar
• Siomi MC, Zhang Y, Siomi H, Dreyfuss G. Specific sequences in the fragile X syndrome protein FMR1 and the FXR proteins mediate their binding to 60S ribosomal subunits and the interactions among them. Mol Cell Biol 1996; 16:3825-32; PMID:8668200; http://dx.doi.org/10.1128/MCB.16.7.3825
   PubMed Web of Science ®Google Scholar
• Qian J, Hassanein M, Hoeksema MD, Harris BK, Zou Y, Chen H, Lu P, Eisenberg R, Wang J, Espinosa A, et al. The RNA binding protein FXR1 is a new driver in the 3q26-29 Alicon and predicts poor prognosis in human cancers. Proc Natl Acad Sci U S A 2015; 112:3469-74; PMID:25733852; http://dx.doi.org/10.1073/pnas.1421975112
   PubMed Web of Science ®Google Scholar
• Bukhari SI, Truesdell SS, Lee S, Kollu S, Classon A, Boukhali M, Jain E, Mortensen RD, Yanagiya A, Sadreyev RI, et al. A Specialized Mechanism of Translation Mediated by FXR1a-Associated MicroRNP in Cellular Quiescence. Mol Cell 2016; 61:760-73; PMID:26942679; http://dx.doi.org/10.1016/j.molcel.2016.02.013
   PubMed Web of Science ®Google Scholar
• Sonenberg N, Hinnebusch AG. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 2009; 136:731-45; PMID:19239892; http://dx.doi.org/10.1016/j.cell.2009.01.042
   PubMed Web of Science ®Google Scholar
• Silvera D, Formenti SC, Schneider RJ. Translational control in cancer. Nat Rev Cancer 2010; 10:254-66; PMID:20332778; http://dx.doi.org/10.1038/nrc2824
   PubMed Web of Science ®Google Scholar
• Hinnebusch AG, Ivanov IP, Sonenberg N. Translational control by 5′-untranslated regions of eukaryotic mRNAs. Science 2016; 352:1413-6; PMID:27313038; http://dx.doi.org/10.1126/science.aad9868
   PubMed Web of Science ®Google Scholar
• Gebauer F, Hentze MW. Molecular mechanisms of translational control. Nat Rev Mol Cell Biol 2004; 5:827-35; PMID:15459663; http://dx.doi.org/10.1038/nrm1488
   PubMed Web of Science ®Google Scholar
• Hinnebusch AG. The scanning mechanism of eukaryotic translation initiation. Annu Rev Biochem 2014; 83:779-812; PMID:24499181; http://dx.doi.org/10.1146/annurev-biochem-060713-035802
   PubMed Web of Science ®Google Scholar
• Gross JD, Moerke NJ, von der Haar T, Lugovskoy AA, Sachs AB, McCarthy JE, Wagner G. Ribosome loading onto the mRNA cap is driven by conformational coupling between eIF4G and eIF4E. Cell 2003; 115:739-50; PMID:14675538; http://dx.doi.org/10.1016/S0092-8674(03)00975-9
   PubMed Web of Science ®Google Scholar
• Ling J, Morley SJ, Pain VM, Marzluff WF, Gallie DR. The histone 3′-terminal stem-loop-binding protein enhances translation through a functional and physical interaction with eukaryotic initiation factor 4G (eIF4G) and eIF3. Mol Cell Biol 2002; 22:7853-67; PMID:12391154; http://dx.doi.org/10.1128/MCB.22.22.7853-7867.2002
   PubMed Web of Science ®Google Scholar
• von Der Haar T, Ball PD, McCarthy JE. Stabilization of eukaryotic initiation factor 4E binding to the mRNA 5′-Cap by domains of eIF4G. J Biol Chem 2000; 275:30551-5; PMID:10887196; http://dx.doi.org/10.1074/jbc.M004565200
   PubMed Web of Science ®Google Scholar
• Tarun SZ, Jr., Wells SE, Deardorff JA, Sachs AB. Translation initiation factor eIF4G mediates in vitro poly(A) tail-dependent translation. Proc Natl Acad Sci U S A 1997; 94:9046-51; PMID:9256432; http://dx.doi.org/10.1073/pnas.94.17.9046
   PubMed Web of Science ®Google Scholar
• Tarun SZ, Jr., Sachs AB. Association of the yeast poly(A) tail binding protein with translation initiation factor eIF-4G. EMBO J 1996; 15:7168-77; PMID:9003792
   PubMed Web of Science ®Google Scholar
• Kahvejian A, Svitkin YV, Sukarieh R, M'Boutchou MN, Sonenberg N. Mammalian poly(A)-binding protein is a eukaryotic translation initiation factor, which acts via multiple mechanisms. Genes Dev 2005; 19:104-13; PMID:15630022; http://dx.doi.org/10.1101/gad.1262905
   PubMed Web of Science ®Google Scholar
• Sonenberg N, Hinnebusch AG. New modes of translational control in development, behavior, and disease. Mol Cell 2007; 28:721-9; PMID:18082597; http://dx.doi.org/10.1016/j.molcel.2007.11.018
   PubMed Web of Science ®Google Scholar
• Gingras AC, Gygi SP, Raught B, Polakiewicz RD, Abraham RT, Hoekstra MF, Aebersold R, Sonenberg N. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev 1999; 13:1422-37; PMID:10364159; http://dx.doi.org/10.1101/gad.13.11.1422
   PubMed Web of Science ®Google Scholar
• Khaleghpour K, Pyronnet S, Gingras AC, Sonenberg N. Translational homeostasis: eukaryotic translation initiation factor 4E control of 4E-binding protein 1 and p70 S6 kinase activities. Mol Cell Biol 1999; 19:4302-10; PMID:10330171; http://dx.doi.org/10.1128/MCB.19.6.4302
   PubMed Web of Science ®Google Scholar
• Carroll M, Borden KL. The oncogene eIF4E: using biochemical insights to target cancer. J Interferon Cytokine Res 2013; 33:227-38; PMID:23472659; http://dx.doi.org/10.1089/jir.2012.0142
   PubMed Web of Science ®Google Scholar
• Pelletier J, Graff J, Ruggero D, Sonenberg N. Targeting the eIF4F translation initiation complex: a critical nexus for cancer development. Cancer Res 2015; 75:250-63; PMID:25593033; http://dx.doi.org/10.1158/0008-5472.CAN-14-2789
   PubMed Web of Science ®Google Scholar
• Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev 2004; 18:1926-45; PMID:15314020; http://dx.doi.org/10.1101/gad.1212704
   PubMed Web of Science ®Google Scholar
• Gingras AC, Svitkin Y, Belsham GJ, Pause A, Sonenberg N. Activation of the translational suppressor 4E-BP1 following infection with encephalomyocarditis virus and poliovirus. Proc Natl Acad Sci U S A 1996; 93:5578-83; PMID:8643618; http://dx.doi.org/10.1073/pnas.93.11.5578
   PubMed Web of Science ®Google Scholar
• Siddiqui N, Sonenberg N. Signalling to eIF4E in cancer. Biochemical Society transactions 2015; 43:763-72; PMID:26517881; http://dx.doi.org/10.1042/BST20150126
   PubMed Web of Science ®Google Scholar
• Holcik M, Sonenberg N. Translational control in stress and apoptosis. Nat Rev Mol Cell Biol 2005; 6:318-27; PMID:15803138; http://dx.doi.org/10.1038/nrm1618
   PubMed Web of Science ®Google Scholar
• Spriggs KA, Stoneley M, Bushell M, Willis AE. Re-programming of translation following cell stress allows IRES-mediated translation to predominate. Biol Cell 2008; 100:27-38; PMID:18072942; http://dx.doi.org/10.1042/BC20070098
   PubMed Web of Science ®Google Scholar
• Spriggs KA, Bushell M, Willis AE. Translational regulation of gene expression during conditions of cell stress. Mol Cell 2010; 40:228-37; PMID:20965418; http://dx.doi.org/10.1016/j.molcel.2010.09.028
   PubMed Web of Science ®Google Scholar
• Topisirovic I, Sonenberg N. mRNA translation and energy metabolism in cancer: the role of the MAPK and mTORC1 pathways. Cold Spring Harb Symp Quant Biol 2011; 76:355-67; PMID:22123850; http://dx.doi.org/10.1101/sqb.2011.76.010785
   PubMedGoogle Scholar
• Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 2011; 12:21-35; PMID:21157483; http://dx.doi.org/10.1038/nrm3025
   PubMed Web of Science ®Google Scholar
• Thoreen CC, Chantranupong L, Keys HR, Wang T, Gray NS, Sabatini DM. A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 2012; 485:109-13; PMID:22552098; http://dx.doi.org/10.1038/nature11083
   PubMed Web of Science ®Google Scholar
• Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell 2012; 149:274-93; PMID:22500797; http://dx.doi.org/10.1016/j.cell.2012.03.017
   PubMed Web of Science ®Google Scholar
• Fonseca BD, Smith EM, Yelle N, Alain T, Bushell M, Pause A. The ever-evolving role of mTOR in translation. Semin Cell Dev Biol 2014; 36:102-12; PMID:25263010; http://dx.doi.org/10.1016/j.semcdb.2014.09.014
   PubMed Web of Science ®Google Scholar
• Sang L, Coller HA, Roberts JM. Control of the reversibility of cellular quiescence by the transcriptional repressor HES1. Science 2008; 321:1095-100; PMID:18719287; http://dx.doi.org/10.1126/science.1155998
   PubMed Web of Science ®Google Scholar
• Coller HA, Sang L, Roberts JM. A new description of cellular quiescence. PLoS biology 2006; 4:e83; PMID:16509772; http://dx.doi.org/10.1371/journal.pbio.0040083
   PubMed Web of Science ®Google Scholar
• Gray JV, Petsko GA, Johnston GC, Ringe D, Singer RA, Werner-Washburne M. “Sleeping beauty:” quiescence in Saccharomyces cerevisiae. Microbiol Mol Biol Rev 2004; 68:187-206; PMID:15187181; http://dx.doi.org/10.1128/MMBR.68.2.187-206.2004
   PubMed Web of Science ®Google Scholar
• Cheung TH, Rando TA. Molecular regulation of stem cell quiescence. Nat Rev Mol Cell Biol 2013; 14(6):329-40; PMID:23698583; http://dx.doi.org/10.1038/nrm3591
   PubMed Web of Science ®Google Scholar
• Morita M, Gravel SP, Chenard V, Sikstrom K, Zheng L, Alain T, Gandin V, Avizonis D, Arguello M, Zakaria C, et al. mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation. Cell Metab 2013; 18:698-711; PMID:24206664; http://dx.doi.org/10.1016/j.cmet.2013.10.001
   PubMed Web of Science ®Google Scholar
• Korner CG, Wormington M, Muckenthaler M, Schneider S, Dehlin E, Wahle E. The deadenylating nuclease (DAN) is involved in poly(A) tail removal during the meiotic maturation of Xenopus oocytes. EMBO J 1998; 17:5427-37; PMID:9736620; http://dx.doi.org/10.1093/emboj/17.18.5427
   PubMed Web of Science ®Google Scholar
• Seal R, Temperley R, Wilusz J, Lightowlers RN, Chrzanowska-Lightowlers ZM. Serum-deprivation stimulates cap-binding by PARN at the expense of eIF4E, consistent with the observed decrease in mRNA stability. Nucleic Acids Res 2005; 33:376-87; PMID:15653638; http://dx.doi.org/10.1093/nar/gki169
   PubMed Web of Science ®Google Scholar
• Radford HE, Meijer HA, de Moor CH. Translational control by cytoplasmic polyadenylation in Xenopus oocytes. Biochimica et biophysica acta 2008; 1779:217-29; PMID:18316045; http://dx.doi.org/10.1016/j.bbagrm.2008.02.002
   PubMed Web of Science ®Google Scholar
• Loayza-Puch F, Drost J, Rooijers K, Lopes R, Elkon R, Agami R. p53 induces transcriptional and translational programs to suppress cell proliferation and growth. Genome biology 2013; 14:R32; PMID:23594524; http://dx.doi.org/10.1186/gb-2013-14-4-r32
   PubMed Web of Science ®Google Scholar
• Lee S, Truesdell SS, Bukhari SI, Lee JH, LeTonqueze O, Vasudevan S. Upregulation of eIF5B controls cell-cycle arrest and specific developmental stages. Proc Natl Acad Sci U S A 2014; 111:E4315-22; PMID:25261552; http://dx.doi.org/10.1073/pnas.1320477111
   PubMedGoogle Scholar
• Pisarev AV, Shirokikh NE, Hellen CU. Translation initiation by factor-independent binding of eukaryotic ribosomes to internal ribosomal entry sites. Comptes rendus biologies 2005; 328:589-605; PMID:15992743; http://dx.doi.org/10.1016/j.crvi.2005.02.004
   PubMed Web of Science ®Google Scholar
• Oh SK, Sarnow P. Gene regulation: translational initiation by internal ribosome binding. Curr Opin Genet Dev 1993; 3:295-300; PMID:8504255; http://dx.doi.org/10.1016/0959-437X(93)90037-P
   PubMedGoogle Scholar
• Johannes G, Sarnow P. Cap-independent polysomal association of natural mRNAs encoding c-myc, BiP, and eIF4G conferred by internal ribosome entry sites. RNA 1998; 4:1500-13; PMID:9848649; http://dx.doi.org/10.1017/S1355838298981080
   PubMed Web of Science ®Google Scholar
• Gray NK, Wickens M. Control of translation initiation in animals. Ann Rev Cell Dev Biol 1998; 14:399-458; PMID:9891789; http://dx.doi.org/10.1146/annurev.cellbio.14.1.399
   PubMed Web of Science ®Google Scholar
• Jackson RJ. Alternative mechanisms of initiating translation of mammalian mRNAs. Biochemical Society transactions 2005; 33:1231-41; PMID:16246087; http://dx.doi.org/10.1042/BST0331231
   PubMed Web of Science ®Google Scholar
• Jackson RJ, Hellen CU, Pestova TV. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat Rev Mol Cell Biol 2010; 11:113-27; PMID:20094052; http://dx.doi.org/10.1038/nrm2838
   PubMed Web of Science ®Google Scholar
• Truesdell SS, Mortensen RD, Seo M, Schroeder JC, Lee JH, LeTonqueze O, Vasudevan S. MicroRNA-mediated mRNA translation activation in quiescent cells and oocytes involves recruitment of a nuclear microRNP. Sci Rep 2012; 2:842; PMID:23150790; http://dx.doi.org/10.1038/srep00842
   PubMed Web of Science ®Google Scholar
• Beilharz TH, Humphreys DT, Clancy JL, Thermann R, Martin DI, Hentze MW, Preiss T. microRNA-mediated messenger RNA deadenylation contributes to translational repression in mammalian cells. PLoS ONE 2009; 4:e6783; PMID:19710908; http://dx.doi.org/10.1371/journal.pone.0006783
   PubMed Web of Science ®Google Scholar
• Wu L, Fan J, Belasco JG. MicroRNAs direct rapid deadenylation of mRNA. Proc Natl Acad Sci U S A 2006; 103:4034-9; PMID:16495412; http://dx.doi.org/10.1073/pnas.0510928103
   PubMed Web of Science ®Google Scholar
• Fabian MR, Mathonnet G, Sundermeier T, Mathys H, Zipprich JT, Svitkin YV, Rivas F, Jinek M, Wohlschlegel J, Doudna JA, et al. Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation. Mol Cell 2009; 35:868-80; PMID:19716330; http://dx.doi.org/10.1016/j.molcel.2009.08.004
   PubMed Web of Science ®Google Scholar
• Zekri L, Huntzinger E, Heimstadt S, Izaurralde E. The silencing domain of GW182 interacts with PABPC1 to promote translational repression and degradation of microRNA targets and is required for target release. Mol Cell Biol 2009; 29:6220-31; PMID:19797087; http://dx.doi.org/10.1128/MCB.01081-09
   PubMed Web of Science ®Google Scholar
• Karim MM, Svitkin YV, Kahvejian A, De Crescenzo G, Costa-Mattioli M, Sonenberg N. A mechanism of translational repression by competition of Paip2 with eIF4G for poly(A) binding protein (PABP) binding. Proc Natl Acad Sci U S A 2006; 103:9494-9; PMID:16772376; http://dx.doi.org/10.1073/pnas.0603701103
   PubMed Web of Science ®Google Scholar
• Yanagiya A, Delbes G, Svitkin YV, Robaire B, Sonenberg N. The poly(A)-binding protein partner Paip2a controls translation during late spermiogenesis in mice. J Clin Investig 2010; 120:3389-400; PMID:20739757; http://dx.doi.org/10.1172/JCI43350
   PubMed Web of Science ®Google Scholar
• Goldstrohm AC, Wickens M. Multifunctional deadenylase complexes diversify mRNA control. Nat Rev Mol Cell Biol 2008; 9:337-44; PMID:18334997; http://dx.doi.org/10.1038/nrm2370
   PubMed Web of Science ®Google Scholar
• Dehlin E, Wormington M, Korner CG, Wahle E. Cap-dependent deadenylation of mRNA. EMBO J 2000; 19:1079-86; PMID:10698948; http://dx.doi.org/10.1093/emboj/19.5.1079
   PubMed Web of Science ®Google Scholar
• Korner CG, Wahle E. Poly(A) tail shortening by a mammalian poly(A)-specific 3′-exoribonuclease. J Biol Chem 1997; 272:10448-56; PMID:9099687; http://dx.doi.org/10.1074/jbc.272.1.96
   PubMed Web of Science ®Google Scholar
• Copeland PR, Wormington M. The mechanism and regulation of deadenylation: identification and characterization of Xenopus PARN. RNA 2001; 7:875-86; PMID:11424938; http://dx.doi.org/10.1017/S1355838201010020
   PubMed Web of Science ®Google Scholar
• Monecke T, Schell S, Dickmanns A, Ficner R. Crystal structure of the RRM domain of poly(A)-specific ribonuclease reveals a novel m(7)G-cap-binding mode. J Mol Biol 2008; 382:827-34; PMID:18694759; http://dx.doi.org/10.1016/j.jmb.2008.07.073
   PubMed Web of Science ®Google Scholar
• Nagata T, Suzuki S, Endo R, Shirouzu M, Terada T, Inoue M, Kigawa T, Kobayashi N, Güntert P, Tanaka A, et al. The RRM domain of poly(A)-specific ribonuclease has a noncanonical binding site for mRNA cap analog recognition. Nucleic Acids Res 2008; 36:4754-67; PMID:18641416; http://dx.doi.org/10.1093/nar/gkn458
   PubMed Web of Science ®Google Scholar
• Wu M, Nilsson P, Henriksson N, Niedzwiecka A, Lim MK, Cheng Z, Kokkoris K, Virtanen A, Song H. Structural basis of m(7)GpppG binding to poly(A)-specific ribonuclease. Structure 2009; 17:276-86; PMID:19217398; http://dx.doi.org/10.1016/j.str.2008.11.012
   PubMed Web of Science ®Google Scholar
• Nilsson P, Henriksson N, Niedzwiecka A, Balatsos NA, Kokkoris K, Eriksson J, Virtanen A. A multifunctional RNA recognition motif in poly(A)-specific ribonuclease with cap and poly(A) binding properties. J Biol Chem 2007; 282:32902-11; PMID:17785461; http://dx.doi.org/10.1074/jbc.M702375200
   PubMed Web of Science ®Google Scholar
• Mendez R, Richter JD. Translational control by CPEB: a means to the end. Nat Rev Mol Cell Biol 2001; 2:521-9; PMID:11433366; http://dx.doi.org/10.1038/35080081
   PubMed Web of Science ®Google Scholar
• Kim JH, Richter JD. RINGO/cdk1 and CPEB mediate poly(A) tail stabilization and translational regulation by ePAB. Genes Dev 2007; 21:2571-9; PMID:17938241; http://dx.doi.org/10.1101/gad.1593007
   PubMed Web of Science ®Google Scholar
• Godwin AR, Kojima S, Green CB, Wilusz J. Kiss your tail goodbye: the role of PARN, Nocturnin, and Angel deadenylases in mRNA biology. Biochimica et biophysica acta 2013; 1829:571-9; PMID:23274303; http://dx.doi.org/10.1016/j.bbagrm.2012.12.004
   PubMed Web of Science ®Google Scholar
• Weill L, Belloc E, Bava FA, Mendez R. Translational control by changes in poly(A) tail length: recycling mRNAs. Nat Struct Mol Biol 2012; 19:577-85; PMID:22664985; http://dx.doi.org/10.1038/nsmb.2311
   PubMed Web of Science ®Google Scholar
• Shukla S, Schmidt JC, Goldfarb KC, Cech TR, Parker R. Inhibition of telomerase RNA decay rescues telomerase deficiency caused by dyskerin or PARN defects. Nat Struct Mol Biol 2016; 23:286-92; PMID:26950371; http://dx.doi.org/10.1038/nsmb.3184
   PubMed Web of Science ®Google Scholar
• Maragozidis P, Papanastasi E, Scutelnic D, Totomi A, Kokkori I, Zarogiannis SG, Kerenidi T, Gourgoulianis KI, Balatsos NA. Poly(A)-specific ribonuclease and Nocturnin in squamous cell lung cancer: prognostic value and impact on gene expression. Mol Cancer 2015; 14:187; PMID:26541675; http://dx.doi.org/10.1186/s12943-015-0457-3
   PubMed Web of Science ®Google Scholar
• Tummala H, Walne A, Collopy L, Cardoso S, de la Fuente J, Lawson S, Powell J, Cooper N, Foster A, Mohammed S, et al. Poly(A)-specific ribonuclease deficiency impacts telomere biology and causes dyskeratosis congenita. The J Clin Investig 2015; 125:2151-60; PMID:25893599; http://dx.doi.org/10.1172/JCI78963
   PubMed Web of Science ®Google Scholar
• Stuart BD, Choi J, Zaidi S, Xing C, Holohan B, Chen R, Choi M, Dharwadkar P, Torres F, Girod CE, et al. Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening. Nat Genet 2015; 47:512-7; PMID:25848748; http://dx.doi.org/10.1038/ng.3278
   PubMed Web of Science ®Google Scholar
• Maragozidis P, Karangeli M, Labrou M, Dimoulou G, Papaspyrou K, Salataj E, Pournaras S, Matsouka P, Gourgoulianis KI, Balatsos NA. Alterations of deadenylase expression in acute leukemias: evidence for poly(a)-specific ribonuclease as a potential biomarker. Acta Haematol 2012; 128:39-46; PMID:22614729; http://dx.doi.org/10.1159/000337418
   PubMed Web of Science ®Google Scholar
• Virtanen A, Henriksson N, Nilsson P, Nissbeck M. Poly(A)-specific ribonuclease (PARN): an allosterically regulated, processive and mRNA cap-interacting deadenylase. Crit Rev Biochem Mol Biol 2013; 48:192-209; PMID:23496118; http://dx.doi.org/10.3109/10409238.2013.771132
   PubMed Web of Science ®Google Scholar
• Zhang X, Devany E, Murphy MR, Glazman G, Persaud M, Kleiman FE. PARN deadenylase is involved in miRNA-dependent degradation of TP53 mRNA in mammalian cells. Nucleic Acids Res 2015; 43:10925-38; PMID:26400160; http://dx.doi.org/10.1093/nar/gkv959
   PubMed Web of Science ®Google Scholar
• Tang W, Tu S, Lee HC, Weng Z, Mello CC. The RNase PARN-1 Trims piRNA 3′ Ends to Promote Transcriptome Surveillance in C. elegans. Cell 2016; 164:974-84; PMID:26919432; http://dx.doi.org/10.1016/j.cell.2016.02.008
   PubMed Web of Science ®Google Scholar
• Yoda M, Cifuentes D, Izumi N, Sakaguchi Y, Suzuki T, Giraldez AJ, Tomari Y. Poly(A)-specific ribonuclease mediates 3′-end trimming of Argonaute2-cleaved precursor microRNAs. Cell Rep 2013; 5:715-26; PMID:24209750; http://dx.doi.org/10.1016/j.celrep.2013.09.029
   PubMed Web of Science ®Google Scholar
• Levy-Strumpf N, Deiss LP, Berissi H, Kimchi A. DAP-5, a novel homolog of eukaryotic translation initiation factor 4G isolated as a putative modulator of gamma interferon-induced programmed cell death. Mol Cell Biol 1997; 17:1615-25; PMID:9032289; http://dx.doi.org/10.1128/MCB.17.3.1615
   PubMed Web of Science ®Google Scholar
• Gradi A, Imataka H, Svitkin YV, Rom E, Raught B, Morino S, Sonenberg N. A novel functional human eukaryotic translation initiation factor 4G. Mol Cell Biol 1998; 18:334-42; PMID:9418880; http://dx.doi.org/10.1128/MCB.18.1.334
   PubMed Web of Science ®Google Scholar
• Henis-Korenblit S, Strumpf NL, Goldstaub D, Kimchi A. A novel form of DAP5 protein accumulates in apoptotic cells as a result of caspase cleavage and internal ribosome entry site-mediated translation. Mol Cell Biol 2000; 20:496-506; PMID:10611228; http://dx.doi.org/10.1128/MCB.20.2.496-506.2000
   PubMed Web of Science ®Google Scholar
• Yamanaka S, Zhang XY, Maeda M, Miura K, Wang S, Farese RV, Jr., Iwao H, Innerarity TL. Essential role of NAT1/p97/DAP5 in embryonic differentiation and the retinoic acid pathway. EMBO J 2000; 19:5533-41; PMID:11032820; http://dx.doi.org/10.1093/emboj/19.20.5533
   PubMed Web of Science ®Google Scholar
• Hundsdoerfer P, Thoma C, Hentze MW. Eukaryotic translation initiation factor 4GI and p97 promote cellular internal ribosome entry sequence-driven translation. Proc Natl Acad Sci U S A 2005; 102:13421-6; PMID:16174738; http://dx.doi.org/10.1073/pnas.0506536102
   PubMed Web of Science ®Google Scholar
• Henis-Korenblit S, Shani G, Sines T, Marash L, Shohat G, Kimchi A. The caspase-cleaved DAP5 protein supports internal ribosome entry site-mediated translation of death proteins. Proc Natl Acad Sci U S A 2002; 99:5400-5; PMID:11943866; http://dx.doi.org/10.1073/pnas.082102499
   PubMed Web of Science ®Google Scholar
• Lee SH, McCormick F. p97/DAP5 is a ribosome-associated factor that facilitates protein synthesis and cell proliferation by modulating the synthesis of cell cycle proteins. EMBO J 2006; 25:4008-19; PMID:16932749; http://dx.doi.org/10.1038/sj.emboj.7601268
   PubMed Web of Science ®Google Scholar
• Nousch M, Reed V, Bryson-Richardson RJ, Currie PD, Preiss T. The eIF4G-homolog p97 can activate translation independent of caspase cleavage. RNA 2007; 13:374-84; PMID:17237356; http://dx.doi.org/10.1261/rna.372307
   PubMed Web of Science ®Google Scholar
• Ramirez-Valle F, Braunstein S, Zavadil J, Formenti SC, Schneider RJ. eIF4GI links nutrient sensing by mTOR to cell proliferation and inhibition of autophagy. The Journal of cell biology 2008; 181:293-307; PMID:18426977; http://dx.doi.org/10.1083/jcb.200710215
   PubMed Web of Science ®Google Scholar
• Liberman N, Gandin V, Svitkin YV, David M, Virgili G, Jaramillo M, Holcik M, Nagar B, Kimchi A, Sonenberg N. DAP5 associates with eIF2beta and eIF4AI to promote Internal Ribosome Entry Site driven translation. Nucleic Acids Res 2015; 43:3764-75; PMID:25779044; http://dx.doi.org/10.1093/nar/gkv205
   PubMed Web of Science ®Google Scholar
• Yoffe Y, David M, Kalaora R, Povodovski L, Friedlander G, Feldmesser E, Ainbinder E, Saada A, Bialik S, Kimchi A. Cap-independent translation by DAP5 controls cell fate decisions in human embryonic stem cells. Genes Dev 2016; 30:1991-2004; PMID:27664238; http://dx.doi.org/10.1101/gad.285239.116
   PubMed Web of Science ®Google Scholar
• Vasudevan S. Posttranscriptional upregulation by microRNAs. Wiley Interdiscip Rev RNA 2012; 3:311-30; PMID:22072587; http://dx.doi.org/10.1002/wrna.121
   PubMed Web of Science ®Google Scholar
• Flemr M, Ma J, Schultz RM, Svoboda P. P-body loss is concomitant with formation of a messenger RNA storage domain in mouse oocytes. Biol Reprod 2010; 82:1008-17; PMID:20075394; http://dx.doi.org/10.1095/biolreprod.109.082057
   PubMed Web of Science ®Google Scholar
• Suh N, Baehner L, Moltzahn F, Melton C, Shenoy A, Chen J, Blelloch R. MicroRNA function is globally suppressed in mouse oocytes and early embryos. Curr Biol 2010; 20:271-7; PMID:20116247; http://dx.doi.org/10.1016/j.cub.2009.12.044
   PubMed Web of Science ®Google Scholar
• Jakymiw A, Lian S, Eystathioy T, Li S, Satoh M, Hamel JC, Fritzler MJ, Chan EK. Disruption of GW bodies impairs mammalian RNA interference. Nat Cell Biol 2005; 7:1267-74; PMID:16284622; http://dx.doi.org/10.1038/ncb1334
   PubMed Web of Science ®Google Scholar
• Yang Z, Jakymiw A, Wood MR, Eystathioy T, Rubin RL, Fritzler MJ, Chan EK. GW182 is critical for the stability of GW bodies expressed during the cell cycle and cell proliferation. J Cell Sci 2004; 117:5567-78; PMID:15494374; http://dx.doi.org/10.1242/jcs.01477
   PubMed Web of Science ®Google Scholar
• Lian S, Jakymiw A, Eystathioy T, Hamel JC, Fritzler MJ, Chan EK. GW bodies, microRNAs and the cell cycle. Cell Cycle 2006; 5:242-5; PMID:16418578; http://dx.doi.org/10.4161/cc.5.3.2410
   PubMed Web of Science ®Google Scholar
• Wang F, Fu XD, Zhou Y, Zhang Y. Down-regulation of the cyclin E1 oncogene expression by microRNA-16-1 induces cell cycle arrest in human cancer cells. BMB Rep 2009; 42:725-30; PMID:19944013; http://dx.doi.org/10.5483/BMBRep.2009.42.11.725
   PubMed Web of Science ®Google Scholar
• Sang L, Roberts JM, Coller HA. Hijacking HES1: how tumors co-opt the anti-differentiation strategies of quiescent cells. Trends Mol Med 2010; 16:17-26; PMID:20022559; http://dx.doi.org/10.1016/j.molmed.2009.11.001
   PubMed Web of Science ®Google Scholar
• Wikman H, Vessella R, Pantel K. Cancer micrometastasis and tumour dormancy. Apmis 2008; 116:754-70; PMID:18834417; http://dx.doi.org/10.1111/j.1600-0463.2008.01033.x
   PubMed Web of Science ®Google Scholar
• Yeh AC, Ramaswamy S. Mechanisms of Cancer Cell Dormancy–Another Hallmark of Cancer? Cancer Res 2015; 75:5014-22; PMID:26354021; http://dx.doi.org/10.1158/0008-5472.CAN-15-1370
   PubMed Web of Science ®Google Scholar
• Pattabiraman DR, Weinberg RA. Tackling the cancer stem cells - what challenges do they pose? Nat Rev Drug Discovery 2014; 13:497-512; PMID:24981363; http://dx.doi.org/10.1038/nrd4253
   PubMed Web of Science ®Google Scholar
• Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer 2009; 9:361-71; PMID:19343034; http://dx.doi.org/10.1038/nrc2628
   PubMed Web of Science ®Google Scholar
• Nenu I, Tudor D, Filip AG, Baldea I. Current position of TNF-alpha in melanomagenesis. Tumour Biol 2015; 36:6589-602; PMID:26279161; http://dx.doi.org/10.1007/s13277-015-3639-0
   PubMed Web of Science ®Google Scholar
• Jiang Y, Zhang C, Chen K, Chen Z, Sun Z, Zhang Z, Ding D, Ren S, Zuo Y. The clinical significance of DC-SIGN and DC-SIGNR, which are novel markers expressed in human colon cancer. PLoS ONE 2014; 9:e114748; PMID:25504222; http://dx.doi.org/10.1371/journal.pone.0114748
   PubMedGoogle Scholar
• Gijzen K, Raymakers RA, Broers KM, Figdor CG, Torensma R. Interaction of acute lymphopblastic leukemia cells with C-type lectins DC-SIGN and L-SIGN. Experimental hematology 2008; 36:860-70; PMID:18375037; http://dx.doi.org/10.1016/j.exphem.2008.02.003
   PubMed Web of Science ®Google Scholar
• Ohtsuka T, Ishibashi M, Gradwohl G, Nakanishi S, Guillemot F, Kageyama R. Hes1 and Hes5 as notch effectors in mammalian neuronal differentiation. EMBO J 1999; 18:2196-207; PMID:10205173; http://dx.doi.org/10.1093/emboj/18.8.2196
   PubMed Web of Science ®Google Scholar
• Katoh M. Integrative genomic analyses on HES/HEY family: Notch-independent HES1, HES3 transcription in undifferentiated ES cells, and Notch-dependent HES1, HES5, HEY1, HEY2, HEYL transcription in fetal tissues, adult tissues, or cancer. Int J Oncol 2007; 31:461-6; PMID:17611704
   PubMed Web of Science ®Google Scholar
• Farnie G, Clarke RB, Spence K, Pinnock N, Brennan K, Anderson NG, Bundred NJ. Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways. J Natl Cancer Institute 2007; 99:616-27; PMID:17440163; http://dx.doi.org/10.1093/jnci/djk133
   PubMed Web of Science ®Google Scholar
• Pradeep CR, Kostler WJ, Lauriola M, Granit RZ, Zhang F, Jacob-Hirsch J, Rechavi G, Nair HB, Hennessy BT, Gonzalez-Angulo AM, et al. Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal filling. Oncogene 2012; 31:907-17; PMID:21743488; http://dx.doi.org/10.1038/onc.2011.279
   PubMed Web of Science ®Google Scholar
• So JY, Wahler J, Das Gupta S, Salerno DM, Maehr H, Uskokovic M, Suh N. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer. J Steroid Biochem Mol Biol 2015; 148:111-21; PMID:25541438; http://dx.doi.org/10.1016/j.jsbmb.2014.12.013
   PubMed Web of Science ®Google Scholar
• Ozpolat B, Akar U, Zorrilla-Calancha I, Vivas-Mejia P, Acevedo-Alvarez M, Lopez-Berestein G. Death-associated protein 5 (DAP5/p97/NAT1) contributes to retinoic acid-induced granulocytic differentiation and arsenic trioxide-induced apoptosis in acute promyelocytic leukemia. Apoptosis : an international journal on programmed cell death 2008; 13:915-28; PMID:18491231; http://dx.doi.org/10.1007/s10495-008-0222-9
   PubMed Web of Science ®Google Scholar
• Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, Berninger P, Rothballer A, Ascano M Jr, Jungkamp AC, Munschauer M, et al. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 2010; 141:129-41; PMID:20371350; http://dx.doi.org/10.1016/j.cell.2010.03.009
   PubMed Web of Science ®Google Scholar
• Ingolia NT, Lareau LF, Weissman JS. Ribosome Profiling of Mouse Embryonic Stem Cells Reveals the Complexity and Dynamics of Mammalian Proteomes. Cell 2011; 147(4):789-802; PMID:22056041; http://dx.doi.org/10.1016/j.cell.2011.10.002
   PubMed Web of Science ®Google Scholar
• Lee S, Liu B, Lee S, Huang S-X, Laurent I, Georges St, Qian S-B. Global mapping of translation initiation sites in mammalian cells at single-nucleotide resolution. Proc Natl Acad Sci U S A 2012; 109(37):E2424-32; PMID:22927429; http://dx.doi.org/10.1073/pnas.1207846109
   PubMed Web of Science ®Google Scholar
• Bazzini AA, Lee MT, Giraldez AJ. Ribosome profiling shows that miR-430 reduces translation before causing mRNA decay in zebrafish. Science 2012; 336(6078):233-7; PMID:22422859; http://dx.doi.org/10.1126/science.1215704
   PubMed Web of Science ®Google Scholar
• Subtelny AO, Eichhorn SW, Chen GR, Sive H, Bartel DP. Poly(A)-tail profiling reveals an embryonic switch in translational control. Nature 2014; 508(7494):66-71; PMID:24476825; http://dx.doi.org/10.1038/nature13007
   PubMed Web of Science ®Google Scholar
• Rissland OS, Hong S-J, Bartel DP. MicroRNA destabilization enables dynamic regulation of the miR-16 family in response to cell-cycle changes. Mol Cell 2011; 43(6):993-1004; PMID:21925387; http://dx.doi.org/10.1016/j.molcel.2011.08.021
   PubMed Web of Science ®Google Scholar
• Liu Q, Fu H, Sun F, Zhang H, Tie Y, Zhu J, Xing R, Sun Z, Zheng X. miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res 2008; 36(16):5391-404; PMID:18701644; http://dx.doi.org/10.1093/nar/gkn522
   PubMed Web of Science ®Google Scholar
• Ishizuka A, Siomi MC, Siomi H. A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins. Genes Dev 2002; 16:2497-508; PMID:12368261; http://dx.doi.org/10.1101/gad.1022002
   PubMed Web of Science ®Google Scholar
• Caudy AA, Myers M, Hannon GJ, Hammond SM. Fragile X-related protein and VIG associate with the RNA interference machinery. Genes Dev 2002; 16:2491-6; PMID:12368260; http://dx.doi.org/10.1101/gad.1025202
   PubMed Web of Science ®Google Scholar